BIOGEN INC. Other Nonoperating Income (Expense)
BIOGEN INC. (BIIB) reported Other Nonoperating Income (Expense) of -$1.10 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-04-29
- BIOGEN INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$1.10M, a 144.00% decline year-over-year.
- BIOGEN INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$36.70M, a 558.75% decline year-over-year.
- BIOGEN INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $15.80M.
- BIOGEN INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$3.30M.
- BIOGEN INC. other nonoperating income (expense) for fiscal 2025 was -$24.70M, a 848.48% decline from fiscal 2024.
- BIOGEN INC. other nonoperating income (expense) for fiscal 2024 was $3.30M.
- BIOGEN INC. other nonoperating income (expense) for fiscal 2023 was -$400.00K, a 103.96% decline from fiscal 2022.
- BIOGEN INC. other nonoperating income (expense) for fiscal 2022 was $10.10M, a 80.36% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$1.10M 10-Q · filed 2026-04-29 | -$37.80M derived: sum of 2 quarters · filed 2026-04-29 | -$22.00M derived: sum of 3 quarters · filed 2026-04-29 | -$25.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | -$36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$20.90M derived: sum of 2 quarters · filed 2026-02-06 | -$24.20M derived: sum of 3 quarters · filed 2026-02-06 | -$24.70M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $15.80M 10-Q · filed 2025-10-30 | $12.50M derived: sum of 2 quarters · filed 2025-10-30 | $12.00M 10-Q · filed 2025-10-30 | $23.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$3.30M 10-Q · filed 2025-07-31 | -$3.80M 10-Q · filed 2025-07-31 | $7.20M derived: sum of 3 quarters · filed 2026-04-29 | $6.40M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $2.50M 10-Q · filed 2026-04-29 | -$500.00K 10-Q · filed 2025-05-01 | $10.50M derived: sum of 2 quarters · filed 2026-04-29 | $9.70M derived: sum of 3 quarters · filed 2026-04-29 | $7.70M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $7.20M derived: sum of 2 quarters · filed 2026-02-06 | $5.20M derived: sum of 3 quarters · filed 2026-02-06 | $3.30M 10-K · filed 2026-02-06 | $29.60M 10-K · filed 2025-02-12 | |||
| 2024-09-30 | -$800.00K 10-Q · filed 2025-10-30 | -$2.80M derived: sum of 2 quarters · filed 2025-10-30 | -$4.70M 10-Q · filed 2025-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | -$2.00M 10-Q · filed 2025-07-31 | -$3.90M 10-Q · filed 2025-07-31 | $800.00K derived: sum of 3 quarters · filed 2026-02-06 | -$2.60M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$1.90M 10-Q · filed 2025-05-01 | $2.80M derived: sum of 2 quarters · filed 2026-02-06 | -$600.00K derived: sum of 3 quarters · filed 2026-02-06 | -$2.90M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $1.30M derived: sum of 2 quarters · filed 2026-02-06 | -$1.00M derived: sum of 3 quarters · filed 2026-02-06 | -$400.00K 10-K · filed 2026-02-06 | $3.50M 10-K · filed 2024-02-14 | |||
| 2023-09-30 | -$3.40M 10-Q · filed 2024-10-30 | -$5.70M derived: sum of 2 quarters · filed 2024-10-30 | -$5.10M 10-Q · filed 2024-10-30 | $30.20M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$2.30M 10-Q · filed 2024-08-01 | -$1.70M 10-Q · filed 2024-08-01 | $33.60M derived: sum of 3 quarters · filed 2025-02-12 | $35.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | $600.00K 10-Q · filed 2024-04-24 | $35.90M derived: sum of 2 quarters · filed 2025-02-12 | $37.60M derived: sum of 3 quarters · filed 2025-02-12 | $11.40M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | $35.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $37.00M derived: sum of 2 quarters · filed 2025-02-12 | $10.80M derived: sum of 3 quarters · filed 2025-02-12 | $10.10M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $1.70M 10-Q · filed 2023-11-08 | -$24.50M derived: sum of 2 quarters · filed 2023-11-08 | -$25.20M 10-Q · filed 2023-11-08 | -$15.60M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | -$26.20M 10-Q · filed 2023-07-25 | -$26.90M 10-Q · filed 2023-07-25 | -$17.30M derived: sum of 3 quarters · filed 2024-02-14 | -$18.30M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$700.00K 10-Q · filed 2023-04-25 | $8.90M derived: sum of 2 quarters · filed 2024-02-14 | $7.90M derived: sum of 3 quarters · filed 2024-02-14 | $4.90M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $8.60M derived: sum of 2 quarters · filed 2024-02-14 | $5.60M derived: sum of 3 quarters · filed 2024-02-14 | $5.60M 10-K · filed 2024-02-14 | -$5.60M 10-K · filed 2022-02-03 | |||
| 2021-09-30 | -$1.00M 10-Q · filed 2022-10-25 | -$4.00M derived: sum of 2 quarters · filed 2022-10-25 | -$4.00M 10-Q · filed 2022-10-25 | -$7.20M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | -$3.00M 10-Q · filed 2022-07-20 | -$2.90M 10-Q · filed 2022-07-20 | -$6.20M derived: sum of 3 quarters · filed 2023-02-15 | -$5.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-03 | -$3.20M derived: sum of 2 quarters · filed 2023-02-15 | -$2.50M derived: sum of 3 quarters · filed 2023-02-15 | $1.70M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$2.60M derived: sum of 2 quarters · filed 2023-02-15 | $1.60M derived: sum of 3 quarters · filed 2023-02-15 | -$2.90M 10-K · filed 2023-02-15 | $2.90M 10-K · filed 2021-02-03 | |||
| 2020-09-30 | $700.00K 10-Q · filed 2021-10-20 | $4.90M derived: sum of 2 quarters · filed 2021-10-20 | $400.00K 10-Q · filed 2021-10-20 | -$35.50M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $4.20M 10-Q · filed 2021-07-22 | -$200.00K 10-Q · filed 2021-07-22 | -$36.20M derived: sum of 3 quarters · filed 2022-02-03 | -$39.90M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$4.40M 10-Q · filed 2021-04-22 | -$40.40M derived: sum of 2 quarters · filed 2022-02-03 | -$44.10M derived: sum of 3 quarters · filed 2022-02-03 | -$51.20M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | -$36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | -$39.70M derived: sum of 2 quarters · filed 2022-02-03 | -$46.80M derived: sum of 3 quarters · filed 2022-02-03 | -$47.00M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | -$3.70M 10-Q · filed 2020-10-21 | -$10.80M derived: sum of 2 quarters · filed 2020-10-21 | -$11.00M 10-Q · filed 2020-10-21 | -$12.70M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$7.10M 10-Q · filed 2020-07-22 | -$7.30M 10-Q · filed 2020-07-22 | -$9.00M derived: sum of 3 quarters · filed 2021-02-03 | -$12.20M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | -$200.00K 10-Q · filed 2020-04-23 | -$1.90M derived: sum of 2 quarters · filed 2021-02-03 | -$5.10M derived: sum of 3 quarters · filed 2021-02-03 | -$8.90M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$4.90M derived: sum of 2 quarters · filed 2021-02-03 | -$8.70M derived: sum of 3 quarters · filed 2021-02-03 | -$10.50M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | -$3.20M 10-Q · filed 2019-10-22 | -$7.00M derived: sum of 2 quarters · filed 2019-10-22 | -$8.80M 10-Q · filed 2019-10-22 | -$14.10M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | -$3.80M 10-Q · filed 2019-07-24 | -$5.60M 10-Q · filed 2019-07-24 | -$10.90M derived: sum of 3 quarters · filed 2020-02-06 | -$16.40M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | -$1.80M 10-Q · filed 2019-04-24 | -$7.10M derived: sum of 2 quarters · filed 2020-02-06 | -$12.60M derived: sum of 3 quarters · filed 2020-02-06 | -$18.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$10.80M derived: sum of 2 quarters · filed 2020-02-06 | -$17.00M derived: sum of 3 quarters · filed 2020-02-06 | -$14.70M 10-K · filed 2020-02-06 | -$13.10M 10-K · filed 2018-02-01 | |||
| 2017-09-30 | -$5.50M 10-Q · filed 2018-10-23 | -$5.10M 10-Q · filed 2017-10-24 | -$11.70M derived: sum of 2 quarters · filed 2018-10-23 | -$9.40M 10-Q · filed 2018-10-23 | -$8.20M 10-Q · filed 2017-10-24 | -$13.40M derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-06-30 | -$6.20M 10-Q · filed 2018-07-24 | -$5.80M 10-Q · filed 2017-07-25 | -$3.90M 10-Q · filed 2018-07-24 | -$3.10M 10-Q · filed 2017-07-25 | -$7.90M derived: sum of 3 quarters · filed 2019-02-06 | -$12.30M derived: sum of 4 quarters · filed 2019-02-06 | ||
| 2017-03-31 | $2.30M 10-Q · filed 2018-04-24 | $2.70M 10-Q · filed 2017-04-25 | -$1.70M derived: sum of 2 quarters · filed 2019-02-06 | -$6.10M derived: sum of 3 quarters · filed 2019-02-06 | -$11.60M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$8.40M derived: sum of 2 quarters · filed 2019-02-06 | -$13.90M derived: sum of 3 quarters · filed 2019-02-06 | -$18.30M 10-K · filed 2019-02-06 | -$217.40M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | -$4.40M 10-Q · filed 2017-10-24 | -$9.90M derived: sum of 2 quarters · filed 2017-10-24 | -$14.30M 10-Q · filed 2017-10-24 | -$21.00M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$5.50M 10-Q · filed 2017-07-25 | -$9.90M 10-Q · filed 2017-07-25 | -$16.60M derived: sum of 3 quarters · filed 2018-02-01 | -$18.60M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | -$4.40M 10-Q · filed 2017-04-25 | -$11.10M derived: sum of 2 quarters · filed 2018-02-01 | -$13.10M derived: sum of 3 quarters · filed 2018-02-01 | -$21.30M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$8.70M derived: sum of 2 quarters · filed 2018-02-01 | -$16.90M derived: sum of 3 quarters · filed 2018-02-01 | -$13.80M 10-K · filed 2018-02-01 | -$123.70M 10-K · filed 2016-02-03 | |||
| 2015-09-30 | -$2.00M 10-Q · filed 2016-10-26 | -$10.20M derived: sum of 2 quarters · filed 2016-10-26 | -$7.10M 10-Q · filed 2016-10-26 | -$25.30M derived: sum of 4 quarters · filed 2017-02-02 | ||||
| 2015-06-30 | -$8.20M 10-Q · filed 2016-07-21 | -$5.10M 10-Q · filed 2016-07-21 | -$23.30M derived: sum of 3 quarters · filed 2017-02-02 | -$27.90M derived: sum of 4 quarters · filed 2017-02-02 | ||||
| 2015-03-31 | $3.10M 10-Q · filed 2016-04-21 | -$14.99M 10-Q · filed 2015-04-24 | -$15.10M derived: sum of 2 quarters · filed 2017-02-02 | -$19.70M derived: sum of 3 quarters · filed 2017-02-02 | -$22.30M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$18.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$22.80M derived: sum of 2 quarters · filed 2017-02-02 | -$25.40M derived: sum of 3 quarters · filed 2017-02-02 | -$25.80M 10-K · filed 2017-02-02 | -$25.78M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$4.60M 10-Q · filed 2015-10-21 | -$16.29M 10-Q · filed 2014-10-22 | -$7.20M derived: sum of 2 quarters · filed 2015-10-21 | -$7.60M 10-Q · filed 2015-10-21 | -$17.03M 10-Q · filed 2014-10-22 | -$18.18M derived: sum of 4 quarters · filed 2016-02-03 | ||
| 2014-06-30 | -$2.60M 10-Q · filed 2015-07-24 | $4.86M 10-Q · filed 2014-07-23 | -$3.00M 10-Q · filed 2015-07-24 | -$740.00K 10-Q · filed 2014-07-23 | -$13.58M derived: sum of 3 quarters · filed 2016-02-03 | -$18.22M derived: sum of 4 quarters · filed 2016-02-03 | ||
| 2014-03-31 | -$5.60M 10-Q · filed 2015-04-24 | -$10.98M derived: sum of 2 quarters · filed 2016-02-03 | -$15.62M derived: sum of 3 quarters · filed 2016-02-03 | -$26.04M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$5.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$10.02M derived: sum of 2 quarters · filed 2016-02-03 | -$20.44M derived: sum of 3 quarters · filed 2016-02-03 | -$34.90M 10-K · filed 2016-02-03 | -$34.93M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | -$4.64M 10-Q · filed 2014-10-22 | -$15.07M derived: sum of 2 quarters · filed 2014-10-22 | -$29.52M 10-Q · filed 2014-10-22 | -$43.81M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | -$10.43M 10-Q · filed 2014-07-23 | -$24.89M 10-Q · filed 2014-07-23 | -$39.17M derived: sum of 3 quarters · filed 2015-02-04 | -$43.72M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$14.46M 10-Q · filed 2014-04-23 | -$28.75M derived: sum of 2 quarters · filed 2015-02-04 | -$33.30M derived: sum of 3 quarters · filed 2015-02-04 | -$30.34M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | -$14.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | -$18.84M derived: sum of 2 quarters · filed 2015-02-04 | -$15.89M derived: sum of 3 quarters · filed 2015-02-04 | -$744.00K 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | -$4.55M 10-Q · filed 2013-10-28 | -$1.60M derived: sum of 2 quarters · filed 2013-10-28 | $13.55M 10-Q · filed 2013-10-28 | $9.57M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $2.95M 10-Q · filed 2013-07-25 | $18.09M 10-Q · filed 2013-07-25 | $14.12M derived: sum of 3 quarters · filed 2014-02-06 | $6.39M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $15.14M 10-Q · filed 2013-04-25 | $11.17M derived: sum of 2 quarters · filed 2014-02-06 | $3.44M derived: sum of 3 quarters · filed 2014-02-06 | -$8.28M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$11.70M derived: sum of 2 quarters · filed 2014-02-06 | -$23.43M derived: sum of 3 quarters · filed 2014-02-06 | -$13.48M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | -$7.73M 10-Q · filed 2012-10-25 | -$19.45M derived: sum of 2 quarters · filed 2012-10-25 | -$9.50M 10-Q · filed 2012-10-25 | -$14.20M derived: sum of 4 quarters · filed 2012-10-25 | ||||
| 2011-06-30 | -$11.73M 10-Q · filed 2012-07-24 | -$1.78M 10-Q · filed 2012-07-24 | -$6.48M derived: sum of 3 quarters · filed 2012-07-24 | -$13.42M derived: sum of 4 quarters · filed 2012-07-24 | ||||
| 2011-03-31 | $9.95M 10-Q · filed 2012-05-01 | $5.25M derived: sum of 2 quarters · filed 2012-05-01 | -$1.69M derived: sum of 3 quarters · filed 2012-05-01 | -$682.00K derived: sum of 4 quarters · filed 2012-05-01 | ||||
| 2010-12-31 | -$4.70M 10-K · filed 2011-02-04 | -$11.64M derived: sum of 2 quarters · filed 2011-10-28 | -$10.63M derived: sum of 3 quarters · filed 2011-10-28 | -$18.98M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | -$6.95M 10-Q · filed 2011-10-28 | -$5.93M derived: sum of 2 quarters · filed 2011-10-28 | -$14.32M 10-Q · filed 2011-10-28 | -$7.92M derived: sum of 4 quarters · filed 2011-10-28 | ||||
| 2010-06-30 | $1.01M 10-Q · filed 2011-07-26 | -$7.37M 10-Q · filed 2011-07-26 | -$974.00K derived: sum of 3 quarters · filed 2011-07-26 | $8.43M derived: sum of 4 quarters · filed 2011-07-26 | ||||
| 2010-03-31 | -$8.39M 10-Q · filed 2011-04-21 | -$1.99M derived: sum of 2 quarters · filed 2011-04-21 | $7.41M derived: sum of 3 quarters · filed 2011-04-21 | $22.11M derived: sum of 4 quarters · filed 2011-04-21 | ||||
| 2009-12-31 | $6.40M 10-K · filed 2011-02-04 | $15.80M derived: sum of 2 quarters · filed 2011-02-04 | $30.50M derived: sum of 3 quarters · filed 2011-02-04 | $37.25M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $9.40M 10-K · filed 2011-02-04 | $9.36M 10-Q · filed 2009-10-21 | $24.10M derived: sum of 2 quarters · filed 2011-02-04 | $30.89M 10-Q · filed 2010-10-26 | -$2.18M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $14.70M 10-K · filed 2011-02-04 | $14.68M 10-Q · filed 2009-07-17 | $21.53M 10-Q · filed 2010-07-20 | -$11.58M derived: sum of 3 quarters · filed 2011-02-04 | -$35.29M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | $6.80M 10-K · filed 2011-02-04 | $6.85M 10-Q · filed 2010-04-20 | -$26.28M derived: sum of 2 quarters · filed 2011-02-04 | -$49.99M derived: sum of 3 quarters · filed 2011-02-04 | -$54.01M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2008-12-31 | -$33.08M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | -$56.79M derived: sum of 2 quarters · filed 2011-02-04 | -$60.81M derived: sum of 3 quarters · filed 2011-02-04 | -$57.73M 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | -$23.71M 10-Q · filed 2009-10-21 | -$27.73M derived: sum of 2 quarters · filed 2009-10-21 | -$24.65M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | -$4.02M 10-Q · filed 2009-07-17 | -$938.00K 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $72.40M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |